PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31472402-4	2020	TB-KDM individuals exhibit significantly higher levels of IFNgamma, IL-2, TNFalpha, IL-17A, IL-1alpha, IL-1beta and IL-6 in comparison to TB-NDM, TB alone and DM alone individuals.	Terbium	0-2	interleukin 2	Homo sapiens	68-72	
31472402-7	2020	TB-NDM individuals are also characterized by significantly diminished TB-antigen stimulated levels of IFNgamma, IL-2, TNFalpha, IL-17A, IL-17F, IL-1alpha, IL-1beta and/or IL-6 at pre-treatment and at 2  months of ATT and IFNgamma, IL-2, IL-1alpha and IL-1beta at post-treatment.	Terbium	0-2	interleukin 2	Homo sapiens	112-116	
31472402-7	2020	TB-NDM individuals are also characterized by significantly diminished TB-antigen stimulated levels of IFNgamma, IL-2, TNFalpha, IL-17A, IL-17F, IL-1alpha, IL-1beta and/or IL-6 at pre-treatment and at 2  months of ATT and IFNgamma, IL-2, IL-1alpha and IL-1beta at post-treatment.	Terbium	0-2	interleukin 2	Homo sapiens	231-235